Form 4: Applied Therapeutics Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Constantine Chinoporos, Chief Operating Officer and Chief Business Officer of Applied Therapeutics, sold 28,117 shares of common stock to cover tax withholding obligations related to vesting of restricted stock units.
Summary
- On February 6, 2025, Constantine Chinoporos, Chief Operating Officer and Chief Business Officer of Applied Therapeutics, sold 28,117 shares of the company's common stock.
- The shares were sold at a price of $0.61 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
- Following the transaction, Chinoporos directly owns 271,883 shares of Applied Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't convey any particularly positive or negative sentiment regarding the company's prospects.
Industry Context
Sales to cover tax obligations are a common practice among corporate executives receiving equity compensation. This transaction is a routine event and doesn't necessarily indicate a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of shares by an officer could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of the stock sale transaction. |
| 02/07/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Form 4, Insider Trading, Stock Sale, Applied Therapeutics, APLT, Chinoporos, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.